OPEN END-TURBO-OPTIONSSCHEIN - INCYTE CO. | Market Closed - BOERSE MUENCHEN 15:36:47 2024-05-31 EDT | ||
| 1.57 EUR | +0.64% |
|
| 3 months | -11.80% | ||
| 6 months | +11.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
INCYTE CORPORATION
Latest news about INCYTE CORPORATION
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 1.57 | +0.64% |
| 24-05-30 | 1.56 | +2.63% |
| 24-05-29 | 1.52 | -.--% |
| 24-05-28 | 1.52 | -3.18% |
| 24-05-27 | 1.57 | -.--% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 03:36 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | INCYTE CORPORATION |
| Issuer | HSBC |
| WKN | HS2DCZ |
| ISIN | DE000HS2DCZ3 |
| Date issued | 2023-09-25 |
| Strike | 40.79 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.55 € |
|---|---|
| Lowest since issue | 0.99 € |
Company Profile
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:
- product sales (85.6%);
- royalties (14.2%);
- income from research and cooperation agreements (0.2%).
Sector
-
Consensus: Incyte Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
57.79
USD
Average target price
72.8
USD
Spread / Average Target
+25.97%
- Stock Market
- Certificates
- Certificat
